Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional Accepts healthy volunteers

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ClinicalTrials.gov ID: NCT07654374

Public ClinicalTrials.gov record NCT07654374. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 12:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-Term Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Multiple Maintenance Doses of Oral Once Daily Aleniglipron for Chronic Weight Management in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is randomized, double-blind, placebo-controlled study of the long-term efficacy, safety, and tolerability of multiple doses of aleniglipron in participants living with overweight or obesity and T2DM. Participants will be randomized to aleniglipron or placebo for a total of 76 weeks of treatment.

Study identification

NCT ID
NCT07654374
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
1,100 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 79 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 16, 2026
Primary completion
Aug 31, 2028
Completion
Oct 31, 2028
Last update posted
Aug 31, 2026

2026 – 2028

United States locations

U.S. sites
74
U.S. states
30
U.S. cities
71
Facility City State ZIP Site status
ACCOMPLISH-2 Research Site Birmingham Alabama 35242 Recruiting
ACCOMPLISH-2 Research Site Chandler Arizona 85225 Recruiting
ACCOMPLISH-2 Research Site Phoenix Arizona 85028 Not yet recruiting
ACCOMPLISH-2 Research Site Sun City West Arizona 85375 Not yet recruiting
ACCOMPLISH-2 Research Site Tucson Arizona 85741 Not yet recruiting
ACCOMPLISH-2 Research Site Little Rock Arkansas 72211 Not yet recruiting
ACCOMPLISH-2 Research Site Escondido California 92025 Not yet recruiting
ACCOMPLISH-2 Research Site Fountain Valley California 92708 Not yet recruiting
ACCOMPLISH-2 Research Site La Jolla California 92123 Recruiting
ACCOMPLISH-2 Research Site Lake Forest California 92630 Not yet recruiting
ACCOMPLISH-2 Research Site Rolling Hills Estates California 90274 Not yet recruiting
ACCOMPLISH-2 Research Site San Diego California 92108 Recruiting
ACCOMPLISH-2 Research Site Tustin California 92780 Not yet recruiting
ACCOMPLISH-2 Research Site Waterbury Connecticut 06708 Not yet recruiting
ACCOMPLISH-2 Research Site Clearwater Florida 33756 Recruiting
ACCOMPLISH-2 Research Site Fort Myers Florida 33912 Recruiting
ACCOMPLISH-2 Research Site Jacksonville Florida 32216 Not yet recruiting
ACCOMPLISH-2 Research Site Leesburg Florida 34748 Recruiting
ACCOMPLISH-2 Research Site Miami Florida 33136 Not yet recruiting
ACCOMPLISH-2 Research Site Ocala Florida 34470 Not yet recruiting
ACCOMPLISH-2 Research Site Ocoee Florida 34761 Not yet recruiting
ACCOMPLISH-2 Research Site Pembroke Pines Florida 33027 Not yet recruiting
ACCOMPLISH-2 Research Site Atlanta Georgia 30329 Recruiting
ACCOMPLISH-2 Research Site Columbus Georgia 31904 Not yet recruiting
ACCOMPLISH-2 Research Site Lawrenceville Georgia 30046 Not yet recruiting
ACCOMPLISH-2 Research Site Union City Georgia 30291 Not yet recruiting
ACCOMPLISH-2 Research Site Woodstock Georgia 30189 Recruiting
ACCOMPLISH-2 Research Site Meridian Idaho 83646 Recruiting
ACCOMPLISH-2 Research Site Des Moines Iowa 50314 Recruiting
ACCOMPLISH-2 Research Site Iowa City Iowa 52242 Not yet recruiting
ACCOMPLISH-2 Research Site Wichita Kansas 67218 Recruiting
ACCOMPLISH-2 Research Site Silver Spring Maryland 20901 Recruiting
ACCOMPLISH-2 Research Site Methuen Massachusetts 01844 Recruiting
ACCOMPLISH-2 Research Site Mankato Minnesota 56001 Recruiting
ACCOMPLISH-2 Research Site Minneapolis Minnesota 55423 Recruiting
ACCOMPLISH-2 Research Site Gulfport Mississippi 39503 Recruiting
ACCOMPLISH-2 Research Site Ridgeland Mississippi 39157 Not yet recruiting
ACCOMPLISH-2 Research Site Chesterfield Missouri 63005 Not yet recruiting
ACCOMPLISH-2 Research Site City of Saint Peters Missouri 63303 Recruiting
ACCOMPLISH-2 Research Site Hazelwood Missouri 63042 Recruiting
ACCOMPLISH-2 Research Site Springfield Missouri 65807 Recruiting
ACCOMPLISH-2 Research Site St Louis Missouri 63141 Not yet recruiting
ACCOMPLISH-2 Research Site Missoula Montana 59804 Recruiting
ACCOMPLISH-2 Research Site Omaha Nebraska 68105 Not yet recruiting
ACCOMPLISH-2 Research Site Las Vegas Nevada 89128 Not yet recruiting
ACCOMPLISH-2 Research Site Albany New York 12206 Not yet recruiting
ACCOMPLISH-2 Research Site Albany New York 12208 Not yet recruiting
ACCOMPLISH-2 Research Site Brooklyn New York 11220 Not yet recruiting
ACCOMPLISH-2 Research Site The Bronx New York 10455 Not yet recruiting
ACCOMPLISH-2 Research Site Charlotte North Carolina 28210 Recruiting
ACCOMPLISH-2 Research Site Durham North Carolina 27710 Not yet recruiting
ACCOMPLISH-2 Research Site Fayetteville North Carolina 28304 Not yet recruiting
ACCOMPLISH-2 Research Site Morehead City North Carolina 23730 Not yet recruiting
ACCOMPLISH-2 Research Site Winston-Salem North Carolina 27104 Recruiting
ACCOMPLISH-2 Research Site Columbus Ohio 43213 Recruiting
ACCOMPLISH-2 Research Site Moore Oklahoma 73160 Recruiting
ACCOMPLISH-2 Research Site Tulsa Oklahoma 74133 Not yet recruiting
ACCOMPLISH-2 Research Site Yukon Oklahoma 73099 Not yet recruiting
ACCOMPLISH-2 Research Site Portland Oregon 97202 Recruiting
ACCOMPLISH-2 Research Site Philadelphia Pennsylvania 19152 Recruiting
ACCOMPLISH-2 Research Site Greer South Carolina 29651 Recruiting
ACCOMPLISH-2 Research Site Nashville Tennessee 37203 Not yet recruiting
ACCOMPLISH-2 Research Site Austin Texas 78704 Recruiting
ACCOMPLISH-2 Research Site Farmers Branch Texas 75234 Not yet recruiting
ACCOMPLISH-2 Research Site Houston Texas 77040 Recruiting
ACCOMPLISH-2 Research Site Houston Texas 77054 Recruiting
ACCOMPLISH-2 Research Site San Antonio Texas 78229 Recruiting
ACCOMPLISH-2 Research Site San Antonio Texas 78230 Not yet recruiting
ACCOMPLISH-2 Research Site Wylie Texas 75098 Not yet recruiting
ACCOMPLISH-2 Research Site Salt Lake City Utah 84107 Not yet recruiting
ACCOMPLISH-2 Research Site Burke Virginia 22015 Not yet recruiting
ACCOMPLISH-2 Research Site Manassas Virginia 20110 Recruiting
ACCOMPLISH-2 Research Site Suffolk Virginia 23435 Recruiting
ACCOMPLISH-2 Research Site Renton Washington 98057 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07654374, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 31, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07654374 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →